<img src="https://r2cdn.perplexity.ai/pplx-full-logo-primary-dark%402x.png" style="height:64px;margin-right:32px"/>

# please summarize and give me markdown README to implement above analysis workflow

Here’s a concise README-style spec you can drop into a repo and adapt.

```markdown
# Claims-Based Causal Modeling Workflow

End-to-end workflow for feature discovery, noise reduction, and causal-oriented modeling using drug exposures, ICD/CPT codes, and classification outcomes.

## 1. Overview

This project builds a classification model on a large, noisy healthcare dataset, then uses model-based feature importance plus pattern- and process-mining to derive a stable covariate set and interpretable tree ensembles for causal analyses.

High-level phases:

1. Feature screening with tree ensembles (CatBoost, Random Forest, XGBoost) + Monte Carlo cross-validation.  
2. Structure discovery and noise reduction with FP-Growth, process mining (bupaR), and dynamic time warping (DTW).  
3. Refitting simpler tree ensembles and exporting JSON trees for formal feature attribution and causal experiments.

---

## 2. Data and Variables

- **Unit of analysis:** e.g., patient-episode, encounter, or claim bundle.  
- **Outcome (Y):** binary classification target (e.g., event yes/no).  
- **Treatments (A):** drug exposure indicators (e.g., one-hot or multi-hot for drugs/regimens).  
- **Covariates (X):**
  - ICD diagnosis codes (possibly grouped/rolled up).  
  - CPT procedure codes.  
  - Demographics and other baseline attributes.  
- **Temporal info:**
  - Timestamps for diagnoses, procedures, and drug administrations.  
  - Episode windows (pre-treatment, treatment, follow-up).

Clearly separate:
- Pre-treatment covariates (used for confounding control).  
- Treatment variables (drugs).  
- Post-treatment variables (mediators / outcomes).

---

## 3. Phase 1: Monte Carlo CV + Feature Importance

Goal: robust, model-agnostic feature ranking on noisy, high-dimensional data.

### 3.1. Monte Carlo Cross-Validation

1. Define number of Monte Carlo iterations `M` (e.g., 50–200).  
2. For each iteration `m`:
   - Randomly split data into train/validation (e.g., 70/30, stratified by Y).  
   - Fit:
     - CatBoost classifier.  
     - Random Forest classifier.  
     - Optionally XGBoost classifier.  

### 3.2. Model-Agnostic Feature Importance

Within each iteration and model:

1. Compute **permutation feature importance** on the validation split using the same metric as the primary objective (e.g., AUC, accuracy, log-loss).  
2. Normalize importance for each model (e.g., divide by sum or max so importances lie in \([0,1]\)).  
3. Store importance vectors:  
   - `imp_catboost[m, feature]`  
   - `imp_rf[m, feature]`  
   - `imp_xgb[m, feature]` (optional)

### 3.3. Aggregation Across Models and Iterations

1. For each feature:
   - Compute per-model averages across iterations:  
     - `mean_imp_catboost[feature] = mean_m imp_catboost[m, feature]`  
     - `mean_imp_rf[feature] = mean_m imp_rf[m, feature]`  
     - `mean_imp_xgb[feature]` (if used)
   - Optionally compute variance/SD for stability.  
2. Combine models:
   - Choose weights based on validation performance (e.g., proportional to mean AUC).  
   - Compute a **combined importance**:  
     \[
     I_{feature} = w_{cb} \cdot mean\_imp\_{catboost} + w_{rf} \cdot mean\_imp\_{rf} + w_{xgb} \cdot mean\_imp\_{xgb}
     \]
3. Initial feature screen:
   - Keep features with `I_feature > 0` and optionally restrict to top `K` or top `p%`.

Output of Phase 1:
- A ranked feature list with:
  - Combined importance.  
  - Stability statistics (e.g., SD across iterations).  

---

## 4. Phase 2: Pattern & Process Mining + DTW

Goal: exploit structure in the selected features and further reduce noise.

### 4.1. Frequent Pattern Mining with FP-Growth

1. Construct transactional data:
   - For each unit/episode, build a set of items:  
     - Selected ICD codes.  
     - Selected CPT codes.  
     - Selected drug indicators (if appropriate as items).  
2. Run FP-Growth:
   - Choose minimum support and confidence thresholds appropriate to sample size.  
   - Extract frequent itemsets and association rules.  
3. Feature refinement:
   - Identify features that:
     - Rarely appear in any frequent pattern.  
     - Are only involved in unstable or extremely low-support patterns.  
   - Mark these for potential removal or down-weighting.

### 4.2. Process Mining with bupaR

1. Construct an **event log**:
   - Case ID: patient/episode ID.  
   - Activity: key event type (diagnosis category, procedure, drug administration, etc.).  
   - Timestamp: event time.  
   - Additional attributes: selected features attached as event or case attributes.
2. Use bupaR (and related packages) to:
   - Discover the control-flow: typical paths, variants, bottlenecks.  
   - Assess where drugs (treatments) occur relative to diagnoses/procedures (covariates).  
3. Feature refinement:
   - Retain features that appear consistently in pre-treatment parts of common pathways.  
   - Consider dropping features that are:
     - Extremely rare in the event log.  
     - Only present downstream of treatment (post-treatment mediators) when building covariate sets.

### 4.3. Dynamic Time Warping (DTW) for Time Series

If you have longitudinal measurements (labs, vitals, utilization over time):

1. Define trajectories (e.g., time series segments) for selected signals per unit.  
2. Use DTW:
   - Compute DTW distances and cluster trajectories.  
   - Identify prototypical shapes / motifs.  
3. Derive time-series features:
   - Distances to cluster centroids.  
   - Cluster membership or motif indicators.  
4. Discard original raw signals or derived features that:
   - Are extremely unstable across Monte Carlo splits.  
   - Do not align with any stable motif clusters.

Output of Phase 2:
- Refined feature set that:
  - Is important for prediction.  
  - Participates in frequent patterns and stable pathways.  
  - Respects process timing (pre-treatment vs post-treatment).  
  - Has reduced noise in high-dimensional time series.

---

## 5. Phase 3: Simpler Ensembles for Attribution & Causality

Goal: fit constrained tree ensembles on the refined feature set and export JSON trees for formal attribution and causal work.

### 5.1. Model Specification

Using the refined feature set:

- **Outcome:** same classification target.  
- **Treatment variables:** explicit drug indicators (A).  
- **Covariates:** pre-treatment ICD/CPT and other baseline features (X).  

Fit:

- A **simpler CatBoost** classifier (e.g., shallow trees, limited number of trees).  
- A **simpler XGBoost** classifier (and optionally Random Forest for comparison).

Design considerations:

- Limit max depth (e.g., 2–4) and number of trees for interpretability.  
- Use regularization and early stopping to avoid overfitting.  
- Consider sample-splitting:
  - Use one sample to learn the partitioning structure.  
  - Use a held-out sample for effect estimation within partitions.

### 5.2. Exporting and Parsing JSON Trees

1. Export fitted CatBoost/XGBoost models to JSON.  
2. From the JSON:
   - Extract all trees, nodes, and leaves.  
   - For each leaf:
     - Store the path conditions (feature thresholds / category splits).  
     - Record leaf predictions and sample counts.  
   - For each observation:
     - Determine leaf membership (per tree and/or across ensemble).  

These paths and leaves define interpretable subgroups for downstream analysis.

### 5.3. Causal-Oriented Analyses (Outline)

With explicit treatment variable(s) and covariates:

1. Clearly define causal question:
   - Example: effect of drug A vs B on outcome Y.  
2. Use trees in one or more of the following ways:
   - Identify subgroups (leaves) where treatment–outcome relationships differ.  
   - Within those subgroups, run:
     - Propensity score models (using covariates X).  
     - Matching / weighting / doubly robust estimators.  
3. Use tree structure + domain knowledge to:
   - Separate true confounders from mediators/post-treatment variables.  
   - Document the covariate set and subgroup definitions transparently using the JSON export.

Output of Phase 3:
- Compact, interpretable tree ensembles (and potentially single trees) with:
  - Well-defined subgroups (based on drugs + ICD/CPT covariates).  
  - Reusable JSON representation for reproducible causal experiments and attribution.

---

## 6. Repository Structure (Suggested)

```

project-root/
README.md                      \# This file
data/
raw/                         \# Original claims/EHR extracts
processed/                   \# Cleaned, encoded, temporally aligned data
code/
01_preprocessing/            \# Cleaning, encoding, temporal alignment
02_mc_cv_importance/         \# Monte Carlo CV + permutation importance
03_pattern_mining/           \# FP-Growth scripts
04_process_mining_bupar/     \# Event-log creation + bupaR analyses
05_dtw_time_series/          \# DTW feature engineering
06_phase3_models/            \# Simplified CatBoost/XGBoost/RF refits
07_json_export_and_parsing/  \# Tree JSON export + parsing utilities
08_causal_analyses/          \# Scripts for PS, matching, leaf-wise estimates
results/
feature_importance/
patterns/
process_models/
dtw_clusters/
models/
causal/
docs/
methodology.md
variable_definitions.md

```

---

## 7. Reproducibility Notes

- Fix random seeds for Monte Carlo splits and model training wherever feasible.  
- Log:
  - Data extraction dates and inclusion/exclusion criteria.  
  - All hyperparameters for each model.  
  - Support/confidence thresholds for FP-Growth, process-mining configs, and DTW parameters.  
- Version control:
  - Keep code in git; tag versions used for major analysis milestones.  
  - Store serialized models and JSON exports with versioned filenames.

---

## 8. Adaptation

This template is intentionally generic.  
Before running the workflow, customize:

- Outcome definition (Y), treatment definitions (A), and covariate windows (X).  
- Monte Carlo CV parameters, model hyperparameters, and thresholds for importance and pattern mining.  
- Any regulatory/PHI constraints on data handling, logging, and artifact storage.
```

If you want, the next step can be to translate this into concrete R/Python entrypoints (e.g., `make` or `targets` pipeline) with function stubs aligned to each phase.
<span style="display:none">[^1][^10][^2][^3][^4][^5][^6][^7][^8][^9]</span>

<div align="center">⁂</div>

[^1]: https://datamanagement.hms.harvard.edu/collect-analyze/documentation-metadata/readme-files

[^2]: https://github.com/biobakery/Analysis-workflows-template

[^3]: https://docs.aws.amazon.com/omics/latest/dev/workflows-readme.html

[^4]: https://data.research.cornell.edu/data-management/sharing/readme/

[^5]: https://pmc.ncbi.nlm.nih.gov/articles/PMC10529918/

[^6]: https://social-science-data-editors.github.io/template_README/template-README.html

[^7]: https://cran.r-project.org/web/packages/projects/readme/README.html

[^8]: https://www.staff.lu.se/research-and-education/research-support/support-research-process/research-data-management/store-and-organise/document-datasets-readme-file

[^9]: https://github.com/othneildrew/Best-README-Template

[^10]: https://blogs.incyclesoftware.com/readme-files-for-internal-projects

